CRP and rheumatoid arthritis: In addition, the percentages of patients achieving ACR50 and ACR70 were comparable for the two treatments throughout period 1, and the subgroup analyses were performed by geographic region, DAS28-CRP concentration, and prior biologic medication for RA, which did not show differences among these subgroups.